[1] |
ZHAO Yangting, CHEN Chongyang, PAN Binjing, LV Xiaoyu, LIU Jingfang.
Trimethylamine N-oxide: the potential target for osteoporosis treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1161-1167.
|
[2] |
YE Sen, CHEN Yanzhen, LAI Liping, ZHONG Lingjian, YU Changzhang.
Comparison on the efficacy and safety of ultrasound-guided and X-ray guided for needle approach of percutaneous vertebroplasty
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 551-557.
|
[3] |
DU Chen, TIAN He, CAO Yang, WANG Yongjun, ZHANG Yan.
Research progress on bone metabolism disorders associated with PCOS elucidated from endocrine hormones
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 328-333.
|
[4] |
DENG Zuyue, HUANG Junjun.
Healing effect of Xianling Gubao plus probiotics on osteoporotic fracture rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1126-1131.
|
[5] |
YU Qinyun, SU Xiaogong, BAO Qiying, CHEN Xiaoyan.
Effect of resveratrol on the Wnt/β-Catenin pathway in ovariectomized osteoporosis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 645-649.
|
[6] |
YU Qinyun, ZHAN Xiaofeng, HUANG Yan.
Effects of formononetin on P38MAPK/MMP-9 signaling pathway in ovariectomized rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1371-1376.
|
[7] |
LI Xiaoli, SHA Nannan, CHEN Nan, WANG Yongjun, ZHANG Yan.
Experimental study progress of smoking- and alcohol-induced osteoporosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1299-1303.
|
[8] |
LIN Zhong, SUN Yuan, DU You-gong, YANG Jian-miao, LIN Jian-qun.
The research progress of plant estrogen genistein in osteoporosis treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 105-111.
|
[9] |
DENG Dun, CHEN Li-qiu, ZHANG Wei-kang, YAN Hai-bo, WANG Zhao-hui, CHEN Xiao-yu, SHI Qi, WANG Yong-jun.
Clinical efficacy of Yiqihuoxuezhuanggu Formula in PMO patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(12): 1383-1387.
|
[10] |
WANG Ping, YIN Tao, ZHOU Bo-ting.
Regulation on miRNA to osteoporosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 110-114.
|
[11] |
PAN Wei-min, WANG Shen-jian, YAN Wei-wen, XIE Quan, ZHOU Ying, WANG Chao-qun.
Comparison of clinic efficacy between 99Tc-MDP and alendronate in patients with senile osteoporosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(9): 1030-1032.
|
[12] |
NA Qing-qing, XIE Hua.
Effects of panax notoginsenosides on bone histomor phometry in rats with hyperlipidemia-induced osteoporosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(3): 277-281.
|
[13] |
GUO Jun-hao, YAO Ru-bing, ZHAO Zhi-ming, CAI Hui.
Analysis on influencing factor of effect for treating postmenopausal osteoporosis with risedronate sodium capsules
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 818-822.
|
[14] |
DING Xiao-kai, LIU Yi, XU Yu-lan, LIN Fan, WANG Yan-fei.
Compound of vitamin D and Calcium or combining with bisphosphonates in preventing bone loss induced by glucocorticoid
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(3): 332-336.
|
[15] |
WANG Yan, TANG Xu-lei.
Effects of resveratrol on the expression of osteoprotegerin and receptor activator for NF-κB ligand in femurs of ovariectomized rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(3): 266-270.
|